Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice

Nature Genetics

Volumn 43, Issue 5, 2011, Pages 470-476

  Vassiliou, George S ^a   Cooper, Jonathan L ^a   Rad, Roland ^a   Li, Juan ^b   Rice, Stephen ^a   Uren, Anthony ^c   Rad, Lena ^a   Ellis, Peter ^a   Andrews, Rob ^a   Banerjee, Ruby ^a   Grove, Carolyn ^a   Wang, Wei ^a   Liu, Pentao ^a   Wright, Penny ^d   Arends, Mark ^d   Bradley, Allan ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GENE MUTATION; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HOX GENE; HUMAN; MOUSE; MYELOPOIESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DISEASE PROGRESSION; GENE EXPRESSION; GENE KNOCK-IN TECHNIQUES; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, MYELOID, ACUTE; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; MYELOPOIESIS; NUCLEAR PROTEINS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

MUS;

EID: 79955469651     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.796     Document Type: Article

References (40)

1. Falini, B. et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N. Engl. J. Med. 352, 254-266 (2005). (Pubitemid 40110814)
2. Alcalay, M. et al. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profle characterized by up-regulation of genes involved in stem-cell maintenance. Blood 106, 899-902 (2005). (Pubitemid 41076430)
3. Dupuy, A.J., Akagi, K., Largaespada, D.A., Copeland, N.G. & Jenkins, N.A. Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436, 221-226 (2005). (Pubitemid 41021267)
4. Collier, L.S., Carlson, C.M., Ravimohan, S., Dupuy, A.J. & Largaespada, D.A. Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 436, 272-276 (2005). (Pubitemid 41021279)
5. Okuwaki, M. The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein. J. Biochem. 143, 441-448 (2008). (Pubitemid 351451762)
6. Grisendi, S., Mecucci, C., Falini, B. & Pandolf, P.P. Nucleophosmin and cancer. Nat Rev. Cancer 6, 493-505 (2006). (Pubitemid 43980539)
7. Hingorani, K., Szebeni, A. & Olson, M.O. Mapping the functional domains of nucleolar protein B23. J. Biol. Chem. 275, 24451-24457 (2000). (Pubitemid 30626537)
8. Falini, B. et al. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. Leukemia 23, 1731-1743 (2009).
9. Falini, B. et al. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. Haematologica 93, 439-442 (2008). (Pubitemid 351398646)
10. Rocquain, J. et al. Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC Cancer 10, 401 (2010).
11. Cheng, K. et al. The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model. Blood 115, 3341-3345 (2010).
12. Sportoletti, P. et al. Npm1 is a haploinsuffcient suppressor of myeloid and lymphoid malignancies in the mouse. Blood 111, 3859-3862 (2008).
13. Lavau, C., Szilvassy, S.J., Slany, R. & Cleary, M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16, 4226-4237 (1997). (Pubitemid 27298175)
14. Kogan, S.C. et al. Bethesda proposals for classifcation of nonlymphoid hematopoietic neoplasms in mice. Blood 100, 238-245 (2002). (Pubitemid 35177453)
15. Smith, G.S., Walford, R.L. & Mickey, M.R. Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F1 hybrids. J. Natl. Cancer Inst. 50, 1195-1213 (1973).
16. Rad, R. et al. PiggyBac transposon mutagenesis: a tool for cancer gene discovery in mice. Science 330, 1104-1107 (2010).
17. Voisin, V., Barat, C., Hoang, T. & Rassart, E. Novel insights into the pathogenesis of the Graff murine leukemia retrovirus. J. Virol. 80, 4026-4037 (2006).
18. de Ridder, J., Uren, A., Kool, J., Reinders, M. & Wessels, L Detecting statistically signifcant common insertion sites in retroviral insertional mutagenesis screens. PLOS Comput. Biol. 2, e166 (2006).
19. Dührsen, U., Stahl, J. & Gough, N.M. In vivo transformation of factor-dependent hemopoietic cells: role of intracisternal A-particle transposition for growth factor gene activation. EMBO J. 9, 1087-1096 (1990).
20. Rogers, S.Y., Bradbury, D., Kozlowski, R. & Russell, N.H. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells. Exp. Hematol. 22, 593-598 (1994). (Pubitemid 24300494)
21. Young, D.C. & Griffn, J.D. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 68, 1178-1181 (1986). (Pubitemid 17186399)
22. Takeda, A., Sarma, N.J., Abdul-Nabi, A.M. & Yaseen, N.R. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins. J. Biol. Chem. 285, 16248-16257 (2010).
23. Kim, R. et al. Genome-based identifcation of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas. J. Virol. 77, 2056-2062 (2003). (Pubitemid 36110018)
24. Lauchle, J.O. et al. Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras. Nature 461, 411-414 (2009).
25. Nakamura, T., Largaespada, D.A., Shaughnessy, J.D. Jr., Jenkins, N.A. & Copeland, N.G. Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukemias. Nat Genet. 12, 149-153 (1996). (Pubitemid 26051294)
26. Ayton, P.M. & Cleary, M.L. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 17, 2298-2307 (2003). (Pubitemid 37128644)
27. Lawrence, H.J. et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89, 1922-1930 (1997). (Pubitemid 27132106)
28. Verhaak, R.G. et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic signifcance. Blood 106, 3747-3754 (2005). (Pubitemid 41739008)
29. Ley, T.J. et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363, 2424-2433 (2010).
30. Liu, P., Jenkins, N.A. & Copeland, N.G. A highly effcient recombineering-based method for generating conditional knockout mutations. Genome Res. 13, 476-484 (2003). (Pubitemid 36395405)
31. Chen, Y.T. & Bradley, A. A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells. Genesis 28, 31-35 (2000).
32. Kühn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427-1429 (1995).
33. Li, J. et al. JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia. Blood 116, 1528-1538 (2010).
34. Yang, Y.H. et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15 (2002).
35. Smyth, G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet Mol. Biol. 3, Article3 (2004).
36. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc., B 57, 289-300 (1995).
37. Uren, A.G. et al. A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sites. Nat. Protoc. 4, 789-798 (2009).
38. Akagi, K., Suzuki, T., Stephens, R.M., Jenkins, N.A. & Copeland, N.G. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res. 32, D523-D527 (2004). (Pubitemid 38081713)
39. Collier, L.S. et al. Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality. Cancer Res. 69, 8429-8437 (2009).
40. Uren, A.G. et al. Large-scale mutagenesis in p19(ARF)-and p53-defcient mice identifes cancer genes and their collaborative networks. Cell 133, 727-741 (2008). (Pubitemid 351637624)